We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current EHC market cap is 11.56B. The company's latest EPS is USD 4.5249 and P/E is 25.06.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.25B | 1.32B | 1.3B | 1.35B | 1.41B |
| Operating Income | 190.8M | 208.2M | 217M | 181.6M | 232.5M |
| Net Income | 87.6M | 112.5M | 114.1M | 108.2M | 120.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.64B | 5.12B | 4.35B | 4.8B | 5.37B |
| Operating Income | 648.5M | 810.5M | 633.1M | 735M | 867.5M |
| Net Income | 284.2M | 412.2M | 271M | 352M | 455.7M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.1B | 6.23B | 6.39B | 6.46B | 6.53B |
| Total Liabilities | 3.81B | 3.83B | 3.86B | 3.73B | 3.69B |
| Total Equity | 2.26B | 2.36B | 2.48B | 2.67B | 2.79B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.45B | 6.86B | 5.64B | 6.1B | 6.53B |
| Total Liabilities | 4.44B | 4.47B | 3.77B | 3.81B | 3.69B |
| Total Equity | 1.97B | 2.36B | 1.83B | 2.26B | 2.79B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 850.8M | 238.8M | 456.2M | 724M | 1B |
| Investing | -602.8M | -129.7M | -288.1M | -449.6M | -653.3M |
| Financing | -197.2M | -40.6M | -90.2M | -179.7M | -330.6M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 704.7M | 715.8M | 705.8M | 850.8M | 1B |
| Investing | -407.5M | -666.3M | -627M | -602.8M | -653.3M |
| Financing | -145.9M | -240.1M | -145.7M | -197.2M | -330.6M |
| Market Cap | 11.56B |
| Price to Earnings Ratio | 25.06 |
| Price to Sales Ratio | 2.13 |
| Price to Cash Ratio | 133.71 |
| Price to Book Ratio | 4.01 |
| Dividend Yield | 0.59% |
| Shares Outstanding | 100.71M |
| Average Volume (1 week) | 1.24M |
| Average Volume (1 Month) | 1.05M |
| 52 Week Change | 34.62% |
| 52 Week High | 114.76 |
| 52 Week Low | 81.45 |
| Spread (Intraday) | 2.62 (2.3%) |
| Company Name | Encompass Health Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.encompasshealth.com |
| Industry | hospitals (8060) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
